Get started
Author

Hsiang-Hsuan Michael Yu

Observed names: Hsiang-Hsuan M Yu, Hsiang-Hsuan M. Yu, Hsiang-hsuan M. Yu, Hsiang‐Hsuan Michael Yu
OpenAlex ID: A5141513192
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
2017 · Prakash Chinnaiyan, Minhee Won, et al. · Neuro-Oncology · 153
Effectiveness of Radiotherapy for Elderly Patients With Glioblastoma
2010 · Jacob Scott, Ya-Yu Tsai, et al. · International Journal of Radiation Oncology*Biology*Physics · 98
Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases
2014 · Kamran A. Ahmed, Jessica M. Freilich, et al. · Journal of Neuro-Oncology · 81
Management of brain metastases in breast cancer: a review of current practices and emerging treatments
2020 · Matthew N. Mills, Nicholas B. Figura, et al. · Breast Cancer Research and Treatment · 74
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
2020 · Barbara J. Fisher, Stephanie L. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 58
Current Treatment of Melanoma Brain Metastasis
2020 · Anupam Rishi, Hsiang-Hsuan Michael Yu · Current Treatment Options in Oncology · 44
Intricacies of human–AI interaction in dynamic decision-making for precision oncology
2025 · Dipesh Niraula, Kyle C. Cuneo, et al. · Nature Communications · 41
PDF
Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases
2016 · Bindiya G. Patel, Kamran A. Ahmed, et al. · Melanoma Research · 38
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases
2021 · Matthew N. Mills, Chelsea Walker, et al. · BMC Cancer · 36
PDF
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
2023 · Ammoren E. Dohm, Justyn Y. Nakashima, et al. · European Journal of Cancer · 26
PDF
Mechanisms of, and Adjuvants for, Bone Pain
2018 · Nicholas Figura, Joshua Smith, et al. · Hematology/Oncology Clinics of North America · 25
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases
2024 · Vaseem M. Khatri, Mariella A. Mestres-Villanueva, et al. · npj Breast Cancer · 24
PDF
Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies
2022 · Sebastian Rubino, Daniel E. Oliver, et al. · Frontiers in Oncology · 24
PDF
Postoperative Stereotactic Radiosurgery Using 5-Gy × 5 Sessions in the Management of Brain Metastases
2016 · Yazan Abuodeh, Kamran A. Ahmed, et al. · World Neurosurgery · 16
The Role of Radiation Therapy in the Management of Cutaneous Melanoma
2010 · Nikhil G. Rao, Hsiang-Hsuan M. Yu, et al. · Surgical Oncology Clinics of North America · 16
Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial
2017 · Clara Y.H. Choi, Heather A. Wakelee, et al. · International Journal of Radiation Oncology*Biology*Physics · 15
Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases
2014 · Kamran A. Ahmed, Siriporn Sarangkasiri, et al. · American Journal of Clinical Oncology · 15
Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI‐guided linear accelerator
2022 · Jasmine A. Graham, Gage Redler, et al. · Journal of Applied Clinical Medical Physics · 14
Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma
2025 · Antonio Omuro, Lisa M DeAngelis, et al. · Neuro-Oncology · 13
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
2023 · Vaseem M. Khatri, Matthew N. Mills, et al. · Journal of Neuro-Oncology · 13
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases
2021 · Matthew N. Mills, Chetna Thawani, et al. · Journal of Neuro-Oncology · 13
Triggered kV Imaging During Spine SBRT for Intrafraction Motion Management
2021 · Jihye Koo, Louis Nardella, et al. · Technology in Cancer Research & Treatment · 13
PDF
Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases
2020 · Austin J. Sim, Kamran A. Ahmed, et al. · American Journal of Clinical Oncology · 13
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs
2021 · Matthew N. Mills, Thrisha K. Potluri, et al. · Breast Cancer Research and Treatment · 12
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study
2025 · Kamran A Ahmed, Younchul Kim, et al. · Journal for ImmunoTherapy of Cancer · 11
Works count: 57
Citation count: 961
H-index: 15
I10-index: 26
Year
Topic
Type